Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Development of a Gold Nanoparticle-Based Lateral-Flow Immunoassay for Pneumocystis Pneumonia Serological Diagnosis at Point-of-Care.

Tomás AL, de Almeida MP, Cardoso F, Pinto M, Pereira E, Franco R, Matos O.

Front Microbiol. 2019 Dec 19;10:2917. doi: 10.3389/fmicb.2019.02917. eCollection 2019.

2.

Morphophysiology of forage peanut submitted to different intensities of defoliation on grazing with sheep.

Costa OAD, Ferreira OGL, Henrique DS, Vaz RZ, Fluck AC, Paris W, Kröning AB, Griffith LAA, Matos OIT.

Trop Anim Health Prod. 2019 Aug 27. doi: 10.1007/s11250-019-02041-7. [Epub ahead of print]

PMID:
31456141
3.

Assessing beliefs and attitudes towards antipsychotic medication from a recovery-based perspective: Psychometric properties of a new scale.

Martins MJRV, Pinto AM, Castilho P, Macedo AF, Pereira AT, Bajouco M, Leite R, Matos O, Morais S, Madeira N, Nogueira V, Roque C, Santos P, Santos T, Santos T, Santos V, Troia AF, Barreto-Carvalho C.

Psychiatry Res. 2019 Mar;273:325-330. doi: 10.1016/j.psychres.2019.01.043. Epub 2019 Jan 12.

PMID:
30677722
4.

Prevalence and genotyping of Pneumocystis jirovecii in renal transplant recipients-preliminary report.

Szydłowicz M, Jakuszko K, Szymczak A, Piesiak P, Kowal A, Kopacz Ż, Wesołowska M, Lobo ML, Matos O, Hendrich AB, Kicia M.

Parasitol Res. 2019 Jan;118(1):181-189. doi: 10.1007/s00436-018-6131-0. Epub 2018 Nov 3.

5.

Editorial: Applying 'omics technologies in chemicals risk assessment.

van Ravenzwaay B, Sauer UG, de Matos O, Poole A.

Regul Toxicol Pharmacol. 2017 Dec;91 Suppl 1:S1-S2. doi: 10.1016/j.yrtph.2017.11.017. No abstract available.

6.

Genotyping of Pneumocystis jirovecii in colonized patients with various pulmonary diseases.

Sokulska M, Kicia M, Wesolowska M, Piesiak P, Kowal A, Lobo ML, Kopacz Z, Hendrich AB, Matos O.

Med Mycol. 2018 Oct 1;56(7):809-815. doi: 10.1093/mmy/myx121.

PMID:
29228377
7.

Diversity of Pneumocystis jirovecii Across Europe: A Multicentre Observational Study.

Alanio A, Gits-Muselli M, Guigue N, Desnos-Ollivier M, Calderon EJ, Di Cave D, Dupont D, Hamprecht A, Hauser PM, Helweg-Larsen J, Kicia M, Lagrou K, Lengerova M, Matos O, Melchers WJG, Morio F, Nevez G, Totet A, White LP, Bretagne S.

EBioMedicine. 2017 Aug;22:155-163. doi: 10.1016/j.ebiom.2017.06.027. Epub 2017 Jun 29.

8.

Importance of tissue sampling, laboratory methods, and patient characteristics for detection of Pneumocystis in autopsied lungs of non-immunosuppressed individuals.

Vargas SL, Ponce C, Bustamante R, Calderón E, Nevez G, De Armas Y, Matos O, Miller RF, Gallo MJ.

Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1711-1716. doi: 10.1007/s10096-017-3006-8. Epub 2017 Jun 5. Review.

9.

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response.

Cordonnier C, Alanio A, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Hauser PM, Lagrou K, Melchers WJ, Helweg-Larsen J, Matos O, Bretagne S, Maertens J; Fifth European Conference on Infections in Leukemia (ECIL-5; a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), The European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN).

J Antimicrob Chemother. 2017 Apr 1;72(4):1266-1268. doi: 10.1093/jac/dkw580. No abstract available.

PMID:
28122911
10.

High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.

Ponce CA, Chabé M, George C, Cárdenas A, Durán L, Guerrero J, Bustamante R, Matos O, Huang L, Miller RF, Vargas SL.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01290-16. doi: 10.1128/AAC.01290-16. Print 2017 Feb.

11.
12.

Portugal and Angola: similarities and differences in Toxoplasma gondii seroprevalence and risk factors in pregnant women.

Lobo ML, Patrocinio G, Sevivas T, DE Sousa B, Matos O.

Epidemiol Infect. 2017 Jan;145(1):30-40. Epub 2016 Sep 9.

PMID:
27608967
13.

ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.

Maertens J, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A, Hauser PM, Lagrou K, Melchers WJ, Helweg-Larsen J, Matos O, Bretagne S, Cordonnier C; 5th European Conference on Infections in Leukaemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organisation for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN).

J Antimicrob Chemother. 2016 Sep;71(9):2397-404. doi: 10.1093/jac/dkw157. Epub 2016 May 12.

PMID:
27550992
14.

ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.

Alanio A, Hauser PM, Lagrou K, Melchers WJ, Helweg-Larsen J, Matos O, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Cordonnier C, Maertens J, Bretagne S; 5th European Conference on Infections in Leukemia (ECIL-5), a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), The European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN).

J Antimicrob Chemother. 2016 Sep;71(9):2386-96. doi: 10.1093/jac/dkw156. Epub 2016 May 12.

PMID:
27550991
15.

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.

Cordonnier C, Cesaro S, Maschmeyer G, Einsele H, Donnelly JP, Alanio A, Hauser PM, Lagrou K, Melchers WJ, Helweg-Larsen J, Matos O, Bretagne S, Maertens J; Fifth European Conference on Infections in Leukemia (ECIL-5), a joint venture of The European Group for Blood and Marrow Transplantation (EBMT), The European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and The European LeukemiaNet (ELN).

J Antimicrob Chemother. 2016 Sep;71(9):2379-85. doi: 10.1093/jac/dkw155. Epub 2016 May 12.

PMID:
27550990
16.

Multicentre study highlighting clinical relevance of new high-throughput methodologies in molecular epidemiology of Pneumocystis jirovecii pneumonia.

Esteves F, de Sousa B, Calderón EJ, Huang L, Badura R, Maltez F, Bassat Q, de Armas Y, Antunes F, Matos O.

Clin Microbiol Infect. 2016 Jun;22(6):566.e9-566.e19. doi: 10.1016/j.cmi.2016.03.013. Epub 2016 Mar 26.

17.

Molecular characterisation of Cryptosporidium (Apicomplexa) in children and cattle in Romania.

Vieira PM, Mederle N, Lobo ML, Imre K, Mederle O, Xiao L, Darabus G, Matos O.

Folia Parasitol (Praha). 2015 Jan 1;62. pii: 2015.002. doi: 10.14411/fp.2015.002.

18.

The 13th International Workshops on Opportunistic Protists (IWOP13).

Calderon EJ, Cushion MT, Xiao L, Lorenzo-Morales J, Matos O, Kaneshiro ES, Weiss LM.

J Eukaryot Microbiol. 2015 Sep-Oct;62(5):701-9. doi: 10.1111/jeu.12221. Epub 2015 May 28.

19.

Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers.

Esteves F, Calé SS, Badura R, de Boer MG, Maltez F, Calderón EJ, van der Reijden TJ, Márquez-Martín E, Antunes F, Matos O.

Clin Microbiol Infect. 2015 Apr;21(4):379.e1-10. doi: 10.1016/j.cmi.2014.11.025. Epub 2014 Dec 4.

20.

Determinants of intensive insulin therapeutic regimens in patients with type 1 diabetes: data from a nationwide multicenter survey in Brazil.

Gomes MB, Negrato CA, Cobas R, Tannus LR, Gonçalves PR, da Silva PC, Carneiro JR, Matheus AS, Dib SA, Azevedo MJ, Nery M, Rodacki M, Zajdenverg L, Montenegro Junior RM, Sepulveda J, Calliari LE, Jezini D, Braga N, Luescher JL, Berardo RS, Arruda-Marques MC, Noronha RM, Manna TD, Salvodelli R, Penha FG, Foss MC, Foss-Freitas MC, Pires AC, Robles FC, Guedes Mde F, Dualib P, Silva SC, Sampaio E, Rea R, Faria AC, Tschiedel B, Lavigne S, Canani LH, Zucatti AT, Coral MH, Pereira DA, Araujo LA, Tolentino M, Pedrosa HC, Prado FA, Rassi N, Araujo LB, Fonseca RM, Guedes AD, Matos OS, Palma CC, Azulay R, Forti AC, Façanha C, Montenegro AP, Melo NH, Rezende KF, Ramos A, Felicio JS, Santos FM.

Diabetol Metab Syndr. 2014 May 31;6:67. doi: 10.1186/1758-5996-6-67. eCollection 2014.

21.

Cryptosporidium spp., Giardia duodenalis, Enterocytozoon bieneusi and other intestinal parasites in young children in Lobata province, Democratic Republic of São Tomé and Principe.

Lobo ML, Augusto J, Antunes F, Ceita J, Xiao L, Codices V, Matos O.

PLoS One. 2014 May 20;9(5):e97708. doi: 10.1371/journal.pone.0097708. eCollection 2014.

22.

Pneumocystis and Pneumocystosis: first meeting of experts from Latin-American and Portuguese-speaking countries - a mini-review.

Esteves F, Medrano FJ, de Armas Y, Wissmann G, Calderón EJ, Matos O.

Expert Rev Anti Infect Ther. 2014 May;12(5):545-8. doi: 10.1586/14787210.2014.894883. Epub 2014 Mar 11.

PMID:
24617414
23.

(1-3)-beta-D-glucan in association with lactate dehydrogenase as biomarkers of Pneumocystis pneumonia (PcP) in HIV-infected patients.

Esteves F, Lee CH, de Sousa B, Badura R, Seringa M, Fernandes C, Gaspar JF, Antunes F, Matos O.

Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1173-80. doi: 10.1007/s10096-014-2054-6. Epub 2014 Feb 3.

PMID:
24487911
24.

Toxoplasma gondii prevalence in cats from Lisbon and in pigs from centre and south of Portugal.

Esteves F, Aguiar D, Rosado J, Costa ML, de Sousa B, Antunes F, Matos O.

Vet Parasitol. 2014 Feb 24;200(1-2):8-12. doi: 10.1016/j.vetpar.2013.12.017. Epub 2013 Dec 28.

PMID:
24418601
25.

Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice.

Lobo ML, Esteves F, de Sousa B, Cardoso F, Cushion MT, Antunes F, Matos O.

PLoS One. 2013 Aug 5;8(8):e70619. doi: 10.1371/journal.pone.0070619. Print 2013.

26.

Unusual coexistence of opportunistic lung infections in a human immunodeficiency virus positive patient suffering from persistent Pneumocystis jirovecii pneumonia: a case report.

Ponces Bento D, Esteves F, Matos O, Miranda AC, Ventura F, Araújo C, Mansinho K.

Rev Port Pneumol. 2013 May-Jun;19(3):129-33. doi: 10.1016/j.rppneu.2013.01.005. Epub 2013 May 11. English, Portuguese.

27.

The 12th International Workshops on Opportunistic Protists (IWOP-12).

Weiss LM, Cushion MT, Didier E, Xiao L, Marciano-Cabral F, Sinai AP, Matos O, Calderon EJ, Kaneshiro ES.

J Eukaryot Microbiol. 2013 May-Jun;60(3):298-308. doi: 10.1111/jeu.12034. Epub 2013 Apr 5.

28.

Chemical composition and bioactivity of different oregano (Origanum vulgare) extracts and essential oil.

Teixeira B, Marques A, Ramos C, Serrano C, Matos O, Neng NR, Nogueira JM, Saraiva JA, Nunes ML.

J Sci Food Agric. 2013 Aug 30;93(11):2707-14. doi: 10.1002/jsfa.6089. Epub 2013 Apr 2.

PMID:
23553824
29.

Cell phenotypic change due to Cryptosporidium parvum infection in immunocompetent mice.

Codices V, Martins C, Novo C, Pinho M, de Sousa B, Lopes A, Borrego M, Matos O.

Acta Parasitol. 2013 Mar;58(1):70-9. doi: 10.2478/s11686-013-0113-2. Epub 2013 Feb 2.

PMID:
23377915
30.

Heterogeneous behavior of lipids according to HbA1c levels undermines the plausibility of metabolic syndrome in type 1 diabetes: data from a nationwide multicenter survey.

Giuffrida FM, Guedes AD, Rocco ER, Mory DB, Dualib P, Matos OS, Chaves-Fonseca RM, Cobas RA, Negrato CA, Gomes MB, Dib SA; Brazilian Type 1 Diabetes Study Group (BrazDiab1SG).

Cardiovasc Diabetol. 2012 Dec 27;11:156. doi: 10.1186/1475-2840-11-156.

31.

Dynamics of cytokines and immunoglobulins serum profiles in primary and secondary Cryptosporidium parvum infection: usefulness of Luminex® xMAP technology.

Codices V, Martins C, Novo C, de Sousa B, Lopes Â, Borrego M, Matos O.

Exp Parasitol. 2013 Jan;133(1):106-13. doi: 10.1016/j.exppara.2012.11.003. Epub 2012 Nov 20.

PMID:
23178641
32.
33.

Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group.

Gomes MB, Cobas RA, Matheus AS, Tannus LR, Negrato CA, Rodacki M, Braga N, Cordeiro MM, Luescher JL, Berardo RS, Nery M, Arruda-Marques MC, Calliari LE, Noronha RM, Manna TD, Zajdenverg L, Salvodelli R, Penha FG, Foss MC, Foss-Freitas MC, Pires AC, Robles FC, Guedes M, Dib SA, Dualib P, Silva SC, Sepulvida J, Almeida HG, Sampaio E, Rea R, Faria AC, Tschiedel B, Lavigne S, Cardozo GA, Azevedo MJ, Canani LH, Zucatti AT, Coral MH, Pereira DA, Araujo LA, Tolentino M, Pedrosa HC, Prado FA, Rassi N, Araujo LB, Fonseca RM, Guedes AD, Matos OS, Faria M, Azulay R, Forti AC, Façanha C, Montenegro AP, Montenegro R Jr, Melo NH, Rezende KF, Ramos A, Felicio JS, Santos FM, Jezini DL, Cordeiro MM.

Diabetol Metab Syndr. 2012 Oct 29;4(1):44. doi: 10.1186/1758-5996-4-44.

34.

Epidemiology of Enterocytozoon bieneusi Infection in Humans.

Matos O, Lobo ML, Xiao L.

J Parasitol Res. 2012;2012:981424. doi: 10.1155/2012/981424. Epub 2012 Oct 3.

35.

Study of the epidemiology of Pneumocystis carinii f. sp. suis in abattoir swine in Portugal.

Esgalhado R, Esteves F, Antunes F, Matos O.

Med Mycol. 2013 Jan;51(1):66-71. doi: 10.3109/13693786.2012.700123. Epub 2012 Aug 2.

PMID:
22852751
36.

Pneumocystis jirovecii multilocus genotyping in pooled DNA samples: a new approach for clinical and epidemiological studies.

Esteves F, Gaspar J, de Sousa B, Antunes F, Mansinho K, Matos O.

Clin Microbiol Infect. 2012 Jun;18(6):E177-84. doi: 10.1111/j.1469-0691.2012.03828.x. Epub 2012 Apr 4.

37.

Microsporidia as emerging pathogens and the implication for public health: a 10-year study on HIV-positive and -negative patients.

Lobo ML, Xiao L, Antunes F, Matos O.

Int J Parasitol. 2012 Feb;42(2):197-205. doi: 10.1016/j.ijpara.2011.12.002. Epub 2012 Jan 8.

PMID:
22265899
38.

Dietary supplementation with omega-3-PUFA-rich fish oil reduces signs of food allergy in ovalbumin-sensitized mice.

de Matos OG, Amaral SS, Pereira da Silva PE, Perez DA, Alvarenga DM, Ferreira AV, Alvarez-Leite J, Menezes GB, Cara DC.

Clin Dev Immunol. 2012;2012:236564. doi: 10.1155/2012/236564. Epub 2011 Nov 17.

39.

Antioxidant and antibacterial activity of essential oil and extracts of bay laurel Laurus nobilis Linnaeus (Lauraceae) from Portugal.

Ramos C, Teixeira B, Batista I, Matos O, Serrano C, Neng NR, Nogueira JM, Nunes ML, Marques A.

Nat Prod Res. 2012;26(6):518-29. doi: 10.1080/14786419.2010.531478. Epub 2011 Jul 15.

PMID:
21756182
40.

Development of a multilocus sequence typing tool for high-resolution genotyping of Enterocytozoon bieneusi.

Feng Y, Li N, Dearen T, Lobo ML, Matos O, Cama V, Xiao L.

Appl Environ Microbiol. 2011 Jul;77(14):4822-8. doi: 10.1128/AEM.02803-10. Epub 2011 May 27.

41.

Molecular characterisation of Cryptosporidium isolates from pre-weaned calves in Romania: is there an actual risk of zoonotic infections?

Imre K, Lobo LM, Matos O, Popescu C, Genchi C, Dărăbuş G.

Vet Parasitol. 2011 Sep 27;181(2-4):321-4. doi: 10.1016/j.vetpar.2011.04.042. Epub 2011 May 6.

PMID:
21612871
42.

Antioxidant and antimicrobial activity of Satureja montana L. extracts.

Serrano C, Matos O, Teixeira B, Ramos C, Neng N, Nogueira J, Nunes ML, Marques A.

J Sci Food Agric. 2011 Jul;91(9):1554-60. doi: 10.1002/jsfa.4347. Epub 2011 Mar 28.

PMID:
21445865
43.

Clinical relevance of multiple single-nucleotide polymorphisms in Pneumocystis jirovecii Pneumonia: development of a multiplex PCR-single-base-extension methodology.

Esteves F, Gaspar J, De Sousa B, Antunes F, Mansinho K, Matos O.

J Clin Microbiol. 2011 May;49(5):1810-5. doi: 10.1128/JCM.02303-10. Epub 2011 Mar 9.

45.

Pneumocystis jirovecii multilocus gene sequencing: findings and implications.

Matos O, Esteves F.

Future Microbiol. 2010 Aug;5(8):1257-67. doi: 10.2217/fmb.10.75. Review.

PMID:
20722602
46.

Population structure of Pneumocystis jirovecii isolated from immunodeficiency virus-positive patients.

Esteves F, Gaspar J, Tavares A, Moser I, Antunes F, Mansinho K, Matos O.

Infect Genet Evol. 2010 Mar;10(2):192-9. doi: 10.1016/j.meegid.2009.12.007. Epub 2010 Jan 7.

PMID:
20060502
47.

Identification of relevant single-nucleotide polymorphisms in Pneumocystis jirovecii: relationship with clinical data.

Esteves F, Gaspar J, Marques T, Leite R, Antunes F, Mansinho K, Matos O.

Clin Microbiol Infect. 2010 Jul;16(7):878-84. doi: 10.1111/j.1469-0691.2009.03030.x. Epub 2009 Aug 29.

48.

Effect of specific exercise training on bone mineral density in women with postmenopausal osteopenia or osteoporosis.

de Matos O, Lopes da Silva DJ, Martinez de Oliveira J, Castelo-Branco C.

Gynecol Endocrinol. 2009 Sep;25(9):616-20. doi: 10.1080/09513590903015593.

PMID:
19533480
49.

Occurrence of Cryptosporidium and Giardia genotypes and subtypes in raw and treated water in Portugal.

Lobo ML, Xiao L, Antunes F, Matos O.

Lett Appl Microbiol. 2009 Jun;48(6):732-7. doi: 10.1111/j.1472-765X.2009.02605.x. Epub 2009 Mar 30.

50.

Implementation of a systematic approach to diabetes in primary care in Bahia, Brazil improves metabolic outcomes: PRODIBA-Programa de Interiorização da Assistência ao Diabetes na Bahia (Project for Dissemination of Diabetes Care in the State of Bahia).

Chaves-Fonseca RM, Matos OS, Lordelo RA, Abreu M, Farias MG, Coutinho JF, Ribeiro MN, Matteoni-Athayde L, Lessa I, Pousada J, Oliveira M, Lopes C, Strock E, Mazze R.

Diabet Med. 2009 Mar;26(3):286-92. doi: 10.1111/j.1464-5491.2008.02656.x.

PMID:
19317824

Supplemental Content

Support Center